Searched for
PHARMA MULTINATIONAL
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...- From ₹5,000 salary to ₹48 crore turnover: Meet Nayana Vaidya, a pharma saleswoman, who built a healthcare distribution company from scratchNayana Vaidya built Om Sai Surgicals from a modest beginning. Her company achieved a turnover of nearly ₹48 crore. Vaidya finds satisfactio...
- A complete guide to nominating for the Most Innovative AI Product Awards 2026Across industries, businesses are moving from AI experimentation to measurable enterprise impact. The Most Innovative AI product awards 202...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Demand for senior technology leaders in India is bucking a slowdown in broader tech hiringAs per experts, many MNCs are considering shifting global tech positions to India, mostly to their GCCs. Ratna Gupta, senior partner, ABC C...
- Aurobindo Pharma approves Rs 800 crore share buyback. Check record date, other key detailsAurobindo Pharma is launching its first share buyback in two years, offering to repurchase over 54 lakh shares at Rs 1,475 each. This tende...
- Elmed Life Sciences raises $2.7 million from Nabard-backed Agrisure FundElmed Life Sciences has raised $2.7 million from Agrisure Fund, which is managed by Nabard-backed Nabventures. The company develops and man...
- Biocon signs up with external law firm to review governance process at vendor firms"The company already has a strong code of conduct and an anti-bribery and anti-corruption clause in its contracts with all its vendors. The...
- In talks with multinational pharma cos for acquisition of brands: Bafna pharmaceuticalsThe Earnings Before Interest Depreciation and Amortization (EBITDA) for the half year ending September 30, 2021 was at Rs 7.43 crore, as ag...
- Amit Rajan on why pharma MNCs are beating Indian counterpartsPatent protection, ban on fixed dose combinations among factors helping pharma MNCs
- Why are companies taking longer to hireOver the last six months, even after multiple rounds of interviews, a pharma multinational is yet to close a position for a site head, said...
- Government hopes to resolve 100 transfer pricing issues by year endAn APA is an agreement between a tax payer—mostly multinationals— and tax authority— CBDT in India—where the transfer pricing methodology i...
- Dilip Shanghvi, second-wealthiest Indian, is the poorest pharma CEOShanghvi’s salary for 2013-14 was Rs 2.73 crore, according to data sifted by ET from filings of leading listed drug companies.
- Organisation of Pharma Producers of India challenges NPPA's decision to bring more drugs under price control in High CourtThis is second suit NPPA is facing on matter after India Pharma Alliance (IPA), a grouping of large domestic drugfirms filed a petition .
- FDI in pharma doubled during April to DecemberThe government had cleared a Rs 5,168 crore proposal of US-based pharma firm Mylan Inc's to acquire Indian generic drugs company Agila Spec...
- GSK Pharma: Investors must be careful of the competitive threats it faces in IndiaWhile the company's performance in the June quarter was strong sequentially, it will be interesting to see GSK's strategies to overcome the...
- Ipca, Indoco Remedies attractive in pharma space: Sudip BandyopadhyayCompanies like Ipca and Indoco Remedies are very attractively priced today.
- Let pharma takeovers beSale of Indian drug companies to multinationals is a way of value creation for Indian entrepreneurs and investors.
- India geared up to tap $31 bn drug outsourcing marketBattling competitive forces due to continued pricing pressure, Indian generic majors are playing a crucial role in the global drug mkt. Hea...
- Novo gets nod to invest in Indian armTHE DECKS have been cleared for Danish pharma multinational Novo Nordisk to invest in its Indian subsidiary Novo Nordisk Pharma India with ...
Load More
